Browsing by Author "Sendur, Mehmet Ali Nahit"

Now showing items 1-1 of 1

Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study

Kahraman, Seda; Hızal, Mutlu; Demirel, Nurçin Çakan; Güven, Deniz Can; Gümüşay, Özge; Uluç, Başak Oyan; Bayram, Ertuğrul; Gülbağcı, Burcu; Yaşar, Alper; Davarcı, Sena Ece; Moçan, Eda Eylemer; Acar, Ömer; Işık, Deniz; Aydın, Esra; Karakaş, Yusuf; Özçelik, Melike; Keser, Murat; Okutur, Sadi Kerem; Eren, Önder; Menekşe, Serkan; Aydın, Dinçer; Yılmaz, Funda; Doğan, Özlem; Özkanlı, Gülhan; Yücel, Hakan; Sunar, Veli; Aybak, Musa Barış; Özdemir, Özlem; Duman, Berna Bozkurt; Keskinkılıç, Merve; Sakalar, Teoman; İnal, Ali; Karaoğlanoğlu, Müge; Aksoy, Asude; Er, Muhammed Muhiddin; Turhal, Nazım Serdar; Kalkan, Nurhan Önal; Sendur, Mehmet Ali Nahit (BMC, 2024)

Highly selective inhibitors of cyclin-dependent kinase 4 and 6 (CDK4/6is) have emerged as a standart of care for first- and second-line therapies in combination with endocrine therapy (ET) for HR+/HER2- metastatic breast ...